Association of Asymmetric and Symmetric Dimethylarginine with Inflammation in the Population-Based Study of Health in Pomerania

Association of Asymmetric and Symmetric Dimethylarginine with Inflammation in the Population-Based Study of Health in Pomerania

The amino acids arginine (Arg), asymmetric (ADMA) and symmetric dimethylarginine (SDMA) are related to nitric oxide (NO) metabolism and potential markers of two different disease entities: cardiovascular disease such as atherosclerosis and systemic inflammation in critically ill patients with sepsis...

Full description

Bibliographic Details
Main Authors:	Martin Sebastian Winkler, Martin Bahls, Rainer H. Böger, Till Ittermann, Marcus Dörr, Nele Friedrich, Edzard Schwedhelm
Format:	Article
Language:	English
Published:	MDPI AG 2023-11-01
Series:	Biomolecules
Subjects:	a proliferation-inducing ligand asymmetric dimethylarginine inflammation soluble cluster of differentiation 30 Study of Health in Pomerania symmetric dimethylarginine
Online Access:	https://www.mdpi.com/2218-273X/13/11/1612

Similar Items

Symmetrical (SDMA) and asymmetrical dimethylarginine (ADMA) in sepsis: high plasma levels as combined risk markers for sepsis survival
by: Martin Sebastian Winkler, et al.
Published: (2018-09-01)

Asymmetric and Symmetric Dimethylarginines as Renal Function Parameters in Paediatric Kidney Diseases: A Literature Review from 2003 to 2022
by: Michalina Jezierska, et al.
Published: (2022-10-01)

The relationship of asymmetric dimethylarginine levels with uncontrolled arterial hypertension and hypertension disease stage
by: Aleksandr N. Stafeev, et al.
Published: (2023-11-01)

Association of dimethylarginines and mediators of inflammation after acute ischemic stroke
by: Chen Shufen, et al.
Published: (2012-11-01)

Relationship of asymmetric dimethylarginine levels with disease severity and pulmonary hypertension in chronic obstructive pulmonary disease
by: Elif Torun Parmaksız, et al.
Published: (2018-01-01)

Comparison of two methods for dimethylarginines quantification
by: Vendula Sudová, et al.
Published: (2024-03-01)

Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC-MS/MS versus ELISA
by: Jente Boelaert, et al.
Published: (2016-05-01)

Asymmetric Dimethylarginine: Clinical Applications in Pediatric Medicine
by: You-Lin Tain, et al.
Published: (2011-02-01)

Toxic Dimethylarginines: Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA)
by: You‐Lin Tain, et al.
Published: (2017-03-01)

Increased Serum Levels of Asymmetric Dimethylarginine and Symmetric Dimethylarginine and Decreased Levels of Arginine in Sudanese Patients with Essential Hypertension
by: Sahar Gamil, et al.
Published: (2020-08-01)

Asymmetric and symmetric dimethylarginine in patients presenting with risk factors for coronary heart disease
by: Ilic Marina, et al.
Published: (2012-10-01)

Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and microalbuminuria
by: Emilie H. Zobel, et al.
Published: (2017-07-01)

Serum symmetric dimethylarginine in older dogs: Reference interval and comparison of a gold standard method with the ELISA
by: Sofie Marynissen, et al.
Published: (2024-03-01)

Changes in nitric oxide inhibitors and mortality in critically ill patients: a cohort study
by: Karoline Myglegård Mortensen, et al.
Published: (2024-08-01)

The effect of haptoglobin genotype on the association of asymmetric dimethylarginine and DDAH 1 polymorphism with diabetic macroangiopathy
by: Shiyun Wang, et al.
Published: (2022-12-01)

Symmetric Dimethylarginine Predicts Previously Undetected Atrial Fibrillation in Patients With Ischemic Stroke
by: Juliane Hannemann, et al.
Published: (2024-09-01)

The relationship between serum asymmetric dimethylarginine levels and radial artery spasm
by: Ibrahim Kocayigit, et al.
Published: (2020-03-01)

Role of Asymmetric Dimethylarginine in Psychiatric Disorders
by: Selma Bozkurt Zincir, et al.
Published: (2014-08-01)

Diurnal Variation of L-Arginine and the Cardiovascular Risk Markers Asymmetric and Symmetric Dimethylarginine and Homoarginine in Rotating Night Shift Workers and Controls
by: Juliane Hannemann, et al.
Published: (2023-08-01)

Nitric Oxide Metabolites and Asymmetric Dimethylarginine Concentrations in Breast Milk
by: Hakan Öztürk, et al.
Published: (2017-04-01)

Nebivolol prevents the increase of asymmetric dimethylarginine and oxidants in hyperhomocysteinemic rats
by: Mustafa Ahmet Huyut
Published: (2019-01-01)

ADMA and C-reactive protein as mortality predictors in dialysis patients
by: Ignjatović Aleksandra, et al.
Published: (2013-06-01)

Asymmetric dimethylarginine and NO metabolites in patients with acute and chronic coronary heart disease
by: A. S. Galyavich, et al.
Published: (2009-02-01)

Symmetric Dimethylarginine is a Promising Biomarker for the Early Detection of Age-Related Kidney Dysfunction in Zoo Felids
by: Youn Soong-Hee, et al.
Published: (2022-09-01)

Plasma levels of catecholamines and asymmetric dimethylarginine levels as predictive values of mortality among hemodialysis patients
by: Dziedzic Marcin, et al.
Published: (2014-06-01)

Nitric Oxide Synthesis Metabolites—As Potential Markers in Chronic Kidney Disease in Children
by: Joanna Piechowicz, et al.
Published: (2022-08-01)

Acute L-Arginine supplementation does not increase nitric oxide production in healthy subjects
by: Alvares Thiago, et al.
Published: (2012-06-01)

Inhibitors of the Hydrolytic Enzyme Dimethylarginine Dimethylaminohydrolase (DDAH): Discovery, Synthesis and Development
by: Rhys B. Murphy, et al.
Published: (2016-05-01)

Raised Plasma Levels of Asymmetric Dimethylarginine Are Associated with Pathological Type and Predict the Therapeutic Effect in Lupus Nephritis Patients Treated with Cyclophosphamide
by: Li Zhang, et al.
Published: (2020-07-01)

ASYMMETRIC DIMETHYLARGININE, THE PROMOTER FACTOR OF CARDIOVASCULAR PATHOLOGIES
by: Anamaria Vîlcea, et al.
Published: (2019-09-01)

Asymmetric dimethylarginine serum concentration in normal weight and obese CKD patients treated with hemodialysis
by: Elham Alipoor, et al.
Published: (2024-09-01)

Pathophysiological Role of Adiponectin, Leptin and Asymmetric Dimethylarginine in the Process of Atherosclerosis
by: Koleva Daniela Iv., et al.
Published: (2016-12-01)

Effect of resistance training on plasma nitric oxide and asymmetric dimethylarginine concentrations in type I diabetic rats
by: Parivash Shekarchizadeh Esfahani, et al.
Published: (2013-01-01)

Asymmetric dimethylarginine is not a marker of arterial damage in children with glomerular kidney diseases
by: Piotr Skrzypczyk, et al.
Published: (2020-01-01)

High plasma concentrations of asymmetric dimethylarginine inhibit ischemic cardioprotection in hypercholesterolemic rats
by: M.B.P. Landim, et al.
Published: (2013-10-01)

High plasma concentrations of asymmetric dimethylarginine inhibit ischemic cardioprotection in hypercholesterolemic rats
by: M.B.P. Landim, et al.
Published: (2013-05-01)

Variability of Symmetric Dimethylarginine in Apparently Healthy Dogs
by: M.A. Kopke, et al.
Published: (2018-03-01)

Altered expression of the L-arginine/nitric oxide pathway in ovarian cancer: metabolic biomarkers and biological implications
by: Linfeng Chen, et al.
Published: (2023-09-01)

Markers of nitric oxide are associated with sepsis severity: an observational study
by: Martin Sebastian Winkler, et al.
Published: (2017-07-01)

ADMA, SDMA and L-arginine may be novel targets in pharmacotherapy for complications due to cardiopulmonary bypass
by: Kahraman Aydin, et al.
Published: (2017-01-01)